Viewing nowAtorvastatin Calcium Trihydrate Tablets 20 mg
Atorvastatin Calcium 21.69mg
Tablet · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

MFDS item code 201400497 · Approved 2014.02.05 · Insurance code 651601680
Improvement of hyperlipidemia; prevention of cardiovascular disease (including myocardial infarction and stroke)
This medicine helps reduce the risk of cardiovascular diseases. It is used particularly to reduce the risk of myocardial infarction, stroke, the need for vascular surgery, and angina, helping to maintain stable heart conditions. It also lowers cholesterol and triglyceride levels in patients with primary hyperlipidemia and dyslipidemia, improving vascular health. It effectively helps control cholesterol levels in pediatric patients aged 10 to 17 who have a family history or high-risk factors. This drug is used as an adjunct to dietary therapy to improve various risk factors associated with heart diseases.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient’s characteristics, taking into consideration the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the treatment goal is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in the group of older patients aged 70 years or older are generally similar to those in the usual adult patient group.
10 ~ 17 years: The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). The dose should be adjusted at intervals of 4 weeks or longer.
This drug may cause muscle-related symptoms, so treatment should be stopped immediately and a physician consulted if severe muscle pain or weakness occurs. This drug may affect liver function, hence it should not be taken by individuals with liver disease or with abnormally high liver function test results. Women who are pregnant, may become pregnant, or are breastfeeding should not take this drug, and fertile women must use appropriate contraception while taking it. Children, especially those under 10 years of age, should not take this drug, and the long-term safety in adolescents under 18 has not been thoroughly studied. Patients with a history of alcohol addiction or liver disease should exercise extra caution when taking this drug, and regular liver function tests are required. This drug may increase the risk of muscle damage when taken with certain medications, so patients taking other medications must inform their doctor or pharmacist. If symptoms such as malaise, fever, myalgia, or muscle weakness occur during treatment, immediate medical attention is advised. Caution should be exercised as taking this drug with grapefruit juice may increase blood drug concentrations; therefore, it is advisable to avoid grapefruit juice consumption. Elderly patients or those with impaired kidney function are at a higher risk of myopathy and should take caution during use; regular monitoring is recommended. In cases of overdose, since there is no specific antidote, treatment should be symptomatic, with testing for liver function and muscle damage.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to prevent air or moisture from entering, and it is best stored at room temperature between 1 to 30 degrees Celsius. This way, the drug's effectiveness can be well maintained.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium 21.69mg
Tablet · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.